Literature DB >> 2327753

In vitro susceptibilities of Plesiomonas shigelloides to 24 antibiotics and antibiotic-beta-lactamase-inhibitor combinations.

R B Clark1, P D Lister, L Arneson-Rotert, J M Janda.   

Abstract

The antibiotic susceptibilities of 29 isolates of Plesiomonas shigelloides were studied with 24 antibiotics and antibiotic-inhibitor combinations. Results indicated that all isolates were susceptible to the cephalosporins, penicillins combined with a beta-lactamase inhibitor, aztreonam, and ciprofloxacin. Most isolates were resistant to the penicillins, possibly via production of a penicillinase.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2327753      PMCID： PMC171540          DOI： 10.1128/AAC.34.1.159

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  8 in total

1.  Chromogenic cephalosporin spot test to detect beta-lactamase in clinically significant bacteria.

Authors:  K Montgomery; L Raymundo; W L Drew
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

2.  Plesiomonas enteric infections in the United States.

Authors:  S D Holmberg; I K Wachsmuth; F W Hickman-Brenner; P A Blake; J J Farmer
Journal:  Ann Intern Med       Date:  1986-11       Impact factor: 25.391

3.  The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans.

Authors:  A von Graevenitz; C Bucher
Journal:  Infection       Date:  1982 Sep-Oct       Impact factor: 3.553

4.  Comparative in vitro activities of selected antimicrobial agents against Aeromonas species and Plesiomonas shigelloides.

Authors:  J F Reinhardt; W L George
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 5.  Clinical disease spectrum and pathogenic factors associated with Plesiomonas shigelloides infections in humans.

Authors:  R A Brenden; M A Miller; J M Janda
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

6.  Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.

Authors:  J R Carlson; S A Thornton; H L DuPont; A H West; J J Mathewson
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

7.  Pseudoappendicitis caused by Plesiomonas shigelloides.

Authors:  K Fischer; T Chakraborty; H Hof; T Kirchner; O Wamsler
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

8.  Clinical features, epidemiology, and treatment of Plesiomonas shigelloides diarrhea.

Authors:  K C Kain; M T Kelly
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948
  8 in total
  3 in total

1.  Some properties of Plesiomonas shigelloides treated with aminoglycosides.

Authors:  A Hostacká; I Ciznár
Journal:  Folia Microbiol (Praha)       Date:  2003       Impact factor: 2.099

Review 2.  Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; R N Brogden
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

3.  Isolation and antimicrobial susceptibility of Plesiomonas shigelloides from great cormorants (Phalacrocorax carbo hanedae) in Gifu and Shiga Prefectures, Japan.

Authors:  Ryota Matsuyama; Naotoshi Kuninaga; Tomoya Morimoto; Tetsuya Shibano; Akiko Sudo; Kazunari Sudo; Makoto Asano; Masatsugu Suzuki; Tetsuo Asai
Journal:  J Vet Med Sci       Date:  2015-04-17       Impact factor: 1.267
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.